GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we handle type 2 diabetes . These new drugs work by mimicking the body’s natural GLP-1 process, https://webnowmedia.com/story7215615/glp-1-a-revolutionary-approach-in-diabetes-treatment